Synthetic antigens for the detection of antibodies to hepatitis C virus

US6287761A · kind A · utility

Assignee

• Innogenetics N.V. · BE

Inventors

• Robert Deleys · Grimbergen, BE
• Dirk Pollet · Schilde, BE
• Geert Maertens · Brugge, BE
• Hugo Van Heuverswijn · Laarne, BE

Key dates

• Filing date: Mar 23, 1999
• Grant date: Sep 11, 2001
• Expiry date: Mar 23, 2019

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S530/826
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Peptide sequences are provided which are capable of mimicking proteins encoded by HCV for use as reagents for screening of blood and blood products for prior exposure to HCV. The peptides are at least 5 amino acids long and can be used in various specific assays for the detection of antibodies to HCV, for the detection of HCV antigens, or as immunogens.